Tapewire

Nasdaq · USD

XENE

Xenon Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
2602
SEC CIK
0001582313
Parsed reports
275

Last 12 months

Inside the activity.

2 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202602
Feb 202600
Mar 2026015
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202603
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2026 Filed Mar 11, 2026 23:21 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
SaleCommon Shares 2,771 $60.11 $166,559.27
Disclosure

SEC source: 0001193125-26-102669 · ownership.xml · nonDerivative · entry 2

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,729

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 19:20 UTC
DiFabio AndreaChief Legal Officer
SaleCommon Shares 2,607 $60.11 $156,701.56
Disclosure

SEC source: 0001193125-26-102667 · ownership.xml · nonDerivative · entry 2

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,893

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 11,269 $60.11 $677,357.05
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 15

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,731

F12 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:21 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
Exercise / conversionPerformance Share Units · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102669 · ownership.xml · derivative · entry 4

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.exercise_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.expiration_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:21 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
GrantPerformance Share Units · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102669 · ownership.xml · derivative · entry 3

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Shares · 7,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · shares: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.exercise_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.expiration_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:21 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
Exercise / conversionCommon Shares 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-102669 · ownership.xml · nonDerivative · entry 1

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 19:20 UTC
DiFabio AndreaChief Legal Officer
Exercise / conversionPerformance Share Units · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102667 · ownership.xml · derivative · entry 4

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.exercise_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.expiration_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 19:20 UTC
DiFabio AndreaChief Legal Officer
GrantPerformance Share Units · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102667 · ownership.xml · derivative · entry 3

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Shares · 7,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · shares: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.exercise_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · derivative.expiration_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 19:20 UTC
DiFabio AndreaChief Legal Officer
Exercise / conversionCommon Shares 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-102667 · ownership.xml · nonDerivative · entry 1

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F1 · price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionPerformance Share Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · derivative · entry 22

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F11 · derivative.exercise_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F11 · derivative.expiration_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
GrantPerformance Share Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · derivative · entry 21

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires not disclosed

F11 · derivative.exercise_price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F11 · shares: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F11 · derivative.exercise_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F11 · derivative.expiration_date: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option · Derivative 65,000 $0.00 Strike: $9.44 $0.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · derivative · entry 20

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 65,000 shares

Expires 2029-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option · Derivative 105,000 $0.00 Strike: $4.75 $0.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · derivative · entry 19

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 105,000 shares

Expires 2028-03-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option · Derivative 25,000 $0.00 Strike: $3.10 $0.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · derivative · entry 18

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 25,000 shares

Expires 2027-10-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option · Derivative 75,000 $0.00 Strike: $8.40 $0.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · derivative · entry 17

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 75,000 shares

Expires 2027-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 20,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 14

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · shares: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

F11 · price: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 65,000 $62.06 $4,033,900.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 13

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F10 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 65,000 $9.44 $613,600.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 12

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 61,652 $60.08 $3,704,052.16
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 11

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F9 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.75 to $60.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 43,348 $59.26 $2,568,802.48
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 10

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,652

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F8 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.745 to $59.735, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 105,000 $4.75 $498,750.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 9

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 2,449 $61.26 $150,025.74
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 8

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $61.055 to $61.555, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 10,072 $60.47 $609,053.84
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 7

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,449

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.05 to $61.035, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 12,479 $59.50 $742,500.50
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 6

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,521

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.03 to $60.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 25,000 $3.10 $77,500.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 5

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 21,515 $60.49 $1,301,442.35
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 4

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.16 to $61.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 31,694 $59.88 $1,897,836.72
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 3

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,515

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.16 to $60.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 21,791 $58.81 $1,281,528.71
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 2

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,209

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.16 to $59.1425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 23:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 75,000 $8.40 $630,000.00
Disclosure

SEC source: 0001193125-26-102666 · ownership.xml · nonDerivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 23:54 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
GrantRestricted Share Units · Derivative 20,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-009238 · ownership.xml · derivative · entry 2

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 23:54 UTC
KENNEY CHRISTOPHER JOHNChief Medical Officer
GrantShare Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $42.15 $0.00
Disclosure

SEC source: 0001193125-26-009238 · ownership.xml · derivative · entry 1

KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Shares · 100,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 18:52 UTC
DiFabio AndreaChief Legal Officer
GrantRestricted Share Units · Derivative 15,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-009232 · ownership.xml · derivative · entry 2

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Shares · 15,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 18:52 UTC
DiFabio AndreaChief Legal Officer
GrantShare Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $42.15 $0.00
Disclosure

SEC source: 0001193125-26-009232 · ownership.xml · derivative · entry 1

DiFabio Andrea · CIK 0001692506 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Shares · 80,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 23:53 UTC
Cline Darren SChief Commercial Officer
GrantRestricted Share Units · Derivative 20,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-009235 · ownership.xml · derivative · entry 2

Cline Darren S · CIK 0001633639 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 23:53 UTC
Cline Darren SChief Commercial Officer
GrantShare Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $42.15 $0.00
Disclosure

SEC source: 0001193125-26-009235 · ownership.xml · derivative · entry 1

Cline Darren S · CIK 0001633639 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Shares · 40,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 23:51 UTC
MORTIMER IANDirector · PRESIDENT & CEO
GrantRestricted Share Units · Derivative 65,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-26-009230 · ownership.xml · derivative · entry 2

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Shares · 65,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.

Read SEC document
January 09, 2026 Filed Jan 9, 2026 23:51 UTC
MORTIMER IANDirector · PRESIDENT & CEO
GrantShare Option (Right to Buy) · Derivative 350,000 $0.00 Strike: $42.15 $0.00
Disclosure

SEC source: 0001193125-26-009230 · ownership.xml · derivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Shares · 350,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: Vesting 25% on January 9, 2027, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
January 02, 2026 Filed Jan 2, 2026 23:49 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $7.49 $0.00
Disclosure

SEC source: 0001193125-26-001172 · ownership.xml · derivative · entry 5

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 40,000 shares

Expires 2026-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
January 02, 2026 Filed Jan 2, 2026 23:49 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 2,062 $44.93 $92,645.66
Disclosure

SEC source: 0001193125-26-001172 · ownership.xml · nonDerivative · entry 3

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $44.91 to $45.125, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
January 02, 2026 Filed Jan 2, 2026 23:49 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 37,938 $44.40 $1,684,447.20
Disclosure

SEC source: 0001193125-26-001172 · ownership.xml · nonDerivative · entry 2

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,062

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $43.91 to $44.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
January 02, 2026 Filed Jan 2, 2026 23:49 UTC
MORTIMER IANDirector · PRESIDENT & CEO
Exercise / conversionCommon Shares 40,000 $7.49 $299,600.00
Disclosure

SEC source: 0001193125-26-001172 · ownership.xml · nonDerivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 00:40 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 2,010 $46.32 $93,103.20
Disclosure

SEC source: 0001193125-25-313147 · ownership.xml · nonDerivative · entry 3

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.02 to $46.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 00:40 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 8,820 $45.59 $402,103.80
Disclosure

SEC source: 0001193125-25-313147 · ownership.xml · nonDerivative · entry 2

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,010

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $45.02 to $46.013, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
December 05, 2025 Filed Dec 10, 2025 00:40 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 14,375 $45.03 $647,306.25
Disclosure

SEC source: 0001193125-25-313147 · ownership.xml · nonDerivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,830

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $45.00 to $45.135, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
November 28, 2025 Filed Dec 4, 2025 01:20 UTC
MORTIMER IANDirector · PRESIDENT & CEO
SaleCommon Shares 97 $45.01 $4,365.97
Disclosure

SEC source: 0001193125-25-307211 · ownership.xml · nonDerivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,205

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:43 UTC
Kelly Thomas PatrickChief Financial Officer
GrantRestricted Share Units · Derivative 30,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001193125-25-242700 · ownership.xml · derivative · entry 2

Kelly Thomas Patrick · CIK 0001410514 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Shares · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.

F2 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:43 UTC
Kelly Thomas PatrickChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $41.90 $0.00
Disclosure

SEC source: 0001193125-25-242700 · ownership.xml · derivative · entry 1

Kelly Thomas Patrick · CIK 0001410514 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Shares · 225,000 shares

Expires 2035-10-14

F1 · derivative.exercise_date: Vesting 25% on October 15, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.

Read SEC document
October 01, 2025 Filed Oct 1, 2025 23:17 UTC
MORTIMER IANDirector · PRESIDENT, CEO & INTERIM CFO
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $7.69 $0.00
Disclosure

SEC source: 0001193125-25-227202 · ownership.xml · derivative · entry 4

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT, CEO & INTERIM CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 25,000 shares

Expires 2025-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 01, 2025 Filed Oct 1, 2025 23:17 UTC
MORTIMER IANDirector · PRESIDENT, CEO & INTERIM CFO
SaleCommon Shares 25,000 $40.16 $1,004,000.00
Disclosure

SEC source: 0001193125-25-227202 · ownership.xml · nonDerivative · entry 2

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT, CEO & INTERIM CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,302

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $40.00 to $40.495, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Read SEC document
October 01, 2025 Filed Oct 1, 2025 23:17 UTC
MORTIMER IANDirector · PRESIDENT, CEO & INTERIM CFO
Exercise / conversionCommon Shares 25,000 $7.69 $192,250.00
Disclosure

SEC source: 0001193125-25-227202 · ownership.xml · nonDerivative · entry 1

MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT, CEO & INTERIM CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.